Mycobacterium tuberculosis septic shock.

BACKGROUND Septic shock due to Mycobacterium tuberculosis (MTB) is an uncommon but well-recognized clinical syndrome. The objective of this study was to describe the unique clinical characteristics, epidemiologic risk factors, and covariates of survival of patients with MTB septic shock in comparison with other bacterial septic shock. METHODS A retrospective nested cohort study was conducted of patients given a diagnosis of MTB septic shock derived from a trinational, 8,670-patient database of patients with septic shock between 1996 and 2007. RESULTS In the database, 53 patients had been given a diagnosis of MTB shock compared with 5,419 with septic shock associated with isolation of more common bacterial pathogens. Patients with MTB and other bacterial septic shock had in-hospital mortality rates of 79.2% and 49.7%, respectively (P < .0001). Of the cases of MTB shock, all but five patients had recognized respiratory tract involvement. Fifty-five percent of patients (29 of 53) were documented (by direct culture or stain) as having disseminated extrapulmonary involvement. Inappropriate and appropriate initial empirical therapy was delivered in 28 patients (52.8%) and 25 patients (47.2%); survival was 7.1% and 36.0%, respectively (P = .0114). Ten patients (18.9%) did not receive anti-MTB therapy; all died. The median time to appropriate antimicrobial therapy for MTB septic shock was 31.0 h (interquartile range, 18.9-71.9 h). Only 11 patients received anti-MTB therapy within 24 h of documentation of hypotension; six of these (54.5%) survived. Only one of 21 patients (4.8%) who started anti-MTB therapy after 24 h survived (P = .0003 vs < 24 h). Survival differences between these time intervals are not significantly different from those seen with bacterial septic shock due to more common bacterial pathogens. CONCLUSIONS MTB septic shock behaves similarly to bacterial septic shock. As with bacterial septic shock, early appropriate antimicrobial therapy appears to improve mortality.

[1]  Chien-Jen Chen,et al.  Association between body-mass index and risk of death in more than 1 million Asians. , 2011, The New England journal of medicine.

[2]  S. Lapinsky,et al.  Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis* , 2010, Critical care medicine.

[3]  R. Chaisson,et al.  Body mass index and risk of tuberculosis and death , 2010, AIDS.

[4]  S. Shah.  Mortality among patients with tuberculosis and associations with HIV status - United States, 1993-2008. , 2010 .

[5]  M. Mathru.  Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock , 2010 .

[6]  Anand Kumar,et al.  Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. , 2009, Chest.

[7]  V. Robison,et al.  Trends in tuberculosis--United States, 2008. , 2009, MMWR. Morbidity and mortality weekly report.

[8]  L. Lynen,et al.  Does Hyponatremia have a Value in the Diagnosis of Extrapulmonary Tuberculosis in HIV-1 Infected Patients in Cambodia? , 2007 .

[9]  C. Hung,et al.  Mycobacterium tuberculosis bacteremia in HIV-negative patients. , 2007, Journal of the Formosan Medical Association = Taiwan yi zhi.

[10]  K. Wood,et al.  Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock* , 2006, Critical care medicine.

[11]  J. Al-Tawfiq,et al.  Susceptibility pattern and epidemiology of Mycobacterium tuberculosis in a Saudi Arabian hospital: a 15-year study from 1989 to 2003. , 2005, Chest.

[12]  J. Cleveland,et al.  Guidelines for infection control in dental health-care settings--2003. , 2003, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[13]  K. Abu-Amero.  Status of antituberculosis drug resistance in Saudi Arabia 1979-98. , 2002, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[14]  J. Lucet,et al.  Delayed treatment contributes to mortality in ICU patients with severe active pulmonary tuberculosis and acute respiratory failure , 2001, Intensive Care Medicine.

[15]  C. Dye,et al.  Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. , 1999, JAMA.

[16]  T. Frieden,et al.  Tuberculosis, AIDS, and death among substance abusers on welfare in New York City. , 1996, The New England journal of medicine.

[17]  L. Gakuu.  Treatment of tuberculosis of the hip , 1996 .

[18]  R. Long,et al.  Tuberculosis as a Primary Cause of Respiratory Failure Requiring Mechanical Ventilation , 1995 .

[19]  R. Long,et al.  Tuberculosis as a primary cause of respiratory failure requiring mechanical ventilation. , 1995, American journal of respiratory and critical care medicine.

[20]  R. Bone.  Guidelines for the Use of Innovative Therapies in Sepsis , 1993 .

[21]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[22]  J. L. Gall,et al.  APACHE II--a severity of disease classification system. , 1986, Critical care medicine.

[23]  W. Knaus,et al.  APACHE II: a severity of disease classification system. , 1985 .

[24]  R. Shalhoub,et al.  The mechanism of hyponatremia in pulmonary tuberculosis. , 1969, Annals of internal medicine.